Literature DB >> 7117365

Inhibition of efferent sympathetic nerve activity by centrally administered paraoxon in the cat.

J H De Neef, P Borgdorff, A J Porsius.   

Abstract

We recently found that central administration of the cholinesterase inhibitor paraoxon lowered blood pressure substantially. It was postulated that the decrease in pressure was mediated by a reduction of sympathetic outflow. In the present study, efferent splanchnic nerve activity in anaesthetized and paralysed cats was recorded, and quantified by measuring the variance of signal amplitude. After administration of 8 micrograms paraoxon into the vertebral arteries, blood pressure and splanchnic nerve activity decreased simultaneously. A mean fall of 46 +/- 6% and 45 +/- 13% (mean +/- S.E.M.) respectively was reached within 12 min and was maintained during the period studied (30 min). When the effect of paraoxon was antagonized by dexetimide, both blood pressure and splanchnic nerve activity returned to control values. Since previous work has shown that the depressor action could not be prevented by efferent vagal blockade it seems likely that the fall in blood pressure after paraoxon was mainly caused by a decreased sympathetic outflow. In addition, we varied the amplifier band width in recording splanchnic nerve activity. The measurement of frequencies between 10 and 225 Hz appeared to be sufficient for studying the change in activity after paraoxon.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7117365     DOI: 10.1016/0014-2999(82)90609-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  The central effects of paraoxon on blood pressure of rabbits after intravenous administration or infusion via a vertebral artery.

Authors:  J H de Neef; A Manneke; A J Porsius
Journal:  Arch Toxicol       Date:  1982-09       Impact factor: 5.153

2.  [Brain changes in parathion poisoning: observations in 42 cases].

Authors:  M Oehmichen; W Schlote; H J Mallach
Journal:  Z Rechtsmed       Date:  1983
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.